Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-15

Clinical Trial Update: Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pemetrexed disodium and cisplatin followed by surgery with or without radiation therapy for malignant pleural mesothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Malignant Mesothelioma | Phase 2 | Status: COMPLETED